Details for New Drug Application (NDA): 204683
✉ Email this page to a colleague
NDA 204683 describes KHEDEZLA, which is a drug marketed by Osmotica Pharm Corp and is included in one NDA. Additional details are available on the KHEDEZLA profile page.
The generic ingredient in KHEDEZLA is desvenlafaxine. There are sixteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the desvenlafaxine profile page.
The generic ingredient in KHEDEZLA is desvenlafaxine. There are sixteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the desvenlafaxine profile page.
Summary for 204683
| Tradename: | KHEDEZLA |
| Applicant: | Osmotica Pharm Corp |
| Ingredient: | desvenlafaxine |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 50MG | ||||
| Approval Date: | Jul 10, 2013 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 100MG | ||||
| Approval Date: | Jul 10, 2013 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
